On November 2-4, at the award ceremony of the first Traditional Chinese Veterinary Medicine Inheritance and Innovation Development Forum held in Guangzhou, Zhejiang Jindakang Animal Health Products Co., Ltd. from Jinhua Economic and Technological Development Zone applied for the "Multiple Traditional Chinese Medicine Thin Layer Fingerprint Complete Information Identification Research and Its Application in Production" project won the 2023 Veterinary New Technology Award of the Chinese Veterinary Association for its R&D innovation and technological advancement in the field of veterinary drugs. At the same time, the project was also selected for the "Great Huanong Cup" Technology Innovative project "Innovative Practice Project Award" (only 5 projects nationwide were selected).

For the first time, this technology introduces the connotation of high-performance liquid phase fingerprint into the field of thin-layer identification, replacing expensive HPLC with several cheap thin-layer plates; replacing the gradient flow of high-performance liquid phase with the gradient developer of thin-layer identification Phase; replace the same component peaks presented in the fingerprint with bright and intuitive spot features of different colors for each component.

Han Guiru, the former director and second-level chief pharmacist of the Traditional Chinese Medicine Office of the Hebei Provincial Institute for Drug Control, who was awarded the title of National Women Inventor and received government subsidies from the State Council, spoke highly of this project. Han Guiru said: "At present, the thin-layer fingerprint full information detection method created by Jin Dakang is unique and can solve the problems of cumbersome quality control methods for traditional Chinese medicine, long detection time, few detection indicators, large amounts of toxic solvents, and the inability to synchronize production and detection. Industry pain points and difficulties, and make positive contributions to promoting technological progress in the industry! ”

According to Zhao Lili, one of the main members of the project team, traditional veterinary and Chinese medicine quality control methods have few detection indicators, cumbersome methods, time-consuming and toxic Disadvantages such as the large amount of harmful solvents prevent overall and comprehensive quality control and evaluation of Chinese medicinal materials, resulting in uneven quality of Chinese veterinary drug preparations and seriously affecting the quality and efficacy of Chinese medicines. In order to strictly control the quality of Chinese medicinal materials, this project established a set of simple, fast and efficient thin-layer fingerprint full information identification methods and identification chromatograms of Chinese medicinal materials to conduct overall quality supervision and evaluation of Chinese medicinal materials from different sources, so as to improve the quality of Chinese veterinary drug preparations. With the significant improvement, the treatment effect has also been significantly improved.

“Through the implementation and application of this project in the field of traditional Chinese veterinary medicine, full-process and efficient quality control will be carried out from medicinal materials to finished products, ensuring that traditional Chinese veterinary medicine products have complete ingredients, high quality and significant curative effects, and will help the high-quality development of China’s animal husbandry industry ! At the same time, the method created by this project is simple, fast and efficient, and can quickly provide quality evaluation and supervision information indicators, which has very high technical value for realizing the modernization of traditional Chinese medicine." Zhao Lili said.

Zhejiang Jindakang Animal Health Products Co., Ltd., founded in 1995, is a technology-based enterprise focusing on the research and development, production and sales of veterinary drugs and feed additives. In recent years, with the strong support of Jinhua Economic and Technological Development Zone, the company has adhered to the path of scientific and technological innovation and development, and has successively established cooperation with Zhejiang University, Jilin University, Nanjing Agricultural University, Northwest Agriculture and Forestry University, Zhejiang Academy of Agricultural Sciences and other scientific research institutions. Long-term scientific research cooperation has resulted in the establishment of the "National Postdoctoral Research Workstation" and the "Zhejiang Science and Technology Enterprise R&D Center". At present, the company has 2 national new veterinary drugs, multiple invention patents, formulated national veterinary drug standards for 15 products, and multiple projects have won provincial and municipal science and technology awards including the first prize of Zhejiang Provincial Science and Technology Award. It has been rated as a national high-tech enterprise, a national science and technology small and medium-sized enterprise, a backbone enterprise of Jinhua Science and Technology Park of the Chinese Academy of Sciences, an agricultural science and technology enterprise in Zhejiang Province, a specialized and new small and medium-sized enterprise in Zhejiang Province, and an intellectual property demonstration enterprise in Zhejiang Province.

The company has successfully developed three series of products, including rapid treatment drugs, preventive health drugs, and production performance improvement drugs, which are mainly traditional Chinese medicines. It has formed Jindakang’s distinctive brand and has become a national brand of banned and restricted antibiotics in the field of traditional Chinese medicine and veterinary drugs. , the main force in reducing antibiotics, and has made great contributions to protecting the safety of human beings from the source of livestock products.